Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Crohn Disease (CD), Ulcerative Colitis (UC), IBD (Inflammatory Bowel Disease). Basic parameters: from 10 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- South Korea
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Convergence Research Platform for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
Overview
This study aims to establish an integrated cohort of patients with inflammatory bowel disease (IBD) from Seoul National University Hospital, Seoul National University Boramae Medical Center, and Seoul National University Bundang Hospital. Through this cohort, we seek to develop a prognostic prediction model for IBD patients and a predictive model for therapeutic responses to biologic agents and small molecule therapies.
Primary outcome measures
- Prediction model in the patients with inflammatory bowel disease for treatment response [Time frame: From enrollment to the end of treatment at 12 weeks]
Eligibility criteria
Inclusion criteria
- Patients aged 10 years or older who have been newly diagnosed with inflammatory bowel disease or are under follow-up monitoring.
Exclusion criteria
- Patients diagnosed with cancer or with a history of cancer treatment.
- Participation may be restricted at the discretion of the medical team.
- Infants and young children under the age of 10.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
South Korea · 1 center
- Seoul National University Hospital — Seoul
Identifiers
NCT: NCT07166588 · 2012-115-1183